We are live on ! Find out more
AFMD

Affimed

Delisted

AFMD was delisted on the 19th of May, 2025.

31 hedge funds and large institutions have $38.1M invested in Affimed in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

0.08% less ownership

Funds ownership: 4.31%4.23% (-0.08%)

9% less funds holding

Funds holding: 3431 (-3)

11% less capital invested

Capital invested by funds: $42.9M → $38.1M (-$4.75M)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

94% less call options, than puts

Call options by funds: $3K | Put options by funds: $48K

Holders
31
Holders Change
-3
Holders Change %
-8.82%
% of All Funds
0.77%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
7
Reduced
7
Closed
6
Calls
$3K
Puts
$48K
Net Calls
-$45K
Net Calls Change
-$18K

AFMD Hedge Fund Activity: Q2 2017 in Review

31 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Affimed (AFMD) for Q2 2017, worth a combined $38.1M — down 11% from $42.9M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of AFMD and 3 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 7 added.

The largest buyer was Telemetry Investments, adding an estimated $707K. The largest seller was OrbiMed, cutting an estimated $487K.

  • 31 institutional investors held Affimed (AFMD) as of Q2 2017, down from 34 in Q1 2017.
  • Funds reported $38.1M of Affimed stock for Q2 2017, down 11% quarter-over-quarter.
  • 3 funds opened new Affimed positions in Q2 2017 and 6 closed out, a net change of -3 holders.
  • The largest Affimed buyer in Q2 2017 was Telemetry Investments, an estimated $707K added.
  • The largest Affimed seller in Q2 2017 was OrbiMed, an estimated $487K sold.

Based on aggregated 13F filings for Q2 2017.